Meet the patent and licensing experts who step in when St. Jude inventions and technologies need to be developed into drugs, therapies, and other tangible products to help patients worldwide.
Read More
Catherine Lam, MD, of St. Jude Global, has spent a year in Geneva—and in airports—enrolling low- and middle-income countries into the WHO Global Initiative for Childhood Cancer to help them improve access to care.
Read More
Quality of Life and Palliative Care will offer medical acupuncture to help manage side effects of cancer treatment beginning in 2020.
Read More
Everything is happening at once during the Graduate School’s 2019-20 academic year. With the school’s first-, second-, and third-year cohorts of PhD students now on campus, all phases of graduate training will be underway.
Read More
A new St. Jude Children’s Research Hospital clinical trial, SJELIOT, is evaluating an adult cancer drug that shows potential for improved treatment of high-risk pediatric brain tumors. This phase I investigation is evaluating the combination of a kinase inhibitor (prexasertib) with established anti-cancer agents in children and adolescents who have recurrent or refractory (unresponsive) medulloblastoma, the most common malignant brain tumor in childhood. Leading SJELIOT is neuro-oncologist Giles Robinson, MD, who is also running the SJDAWN clinical trial. “We are very excited to launch this clinical trial,” Robinson said, “since it translates years of very promising laboratory work by...
Read More
